Loading…
P3 Health Partners Inc. is projected to decline to $10.16 by 2027, a -1% move from its current price of $10.22. PIII is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $9.73 | $10.23 | $10.76 | +0.09% |
| Aug 2 | $9.54 | $10.24 | $10.99 | +0.19% |
| Aug 3 | $9.40 | $10.25 | $11.18 | +0.28% |
| Aug 4 | $9.28 | $10.26 | $11.34 | +0.37% |
| Aug 5 | $9.18 | $10.27 | $11.49 | +0.47% |
| Aug 6 | $9.09 | $10.28 | $11.62 | +0.56% |
| Aug 7 | $9.01 | $10.29 | $11.75 | +0.65% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.01 | $10.29 | $11.75 | +0.65% |
| Week 2 | $8.58 | $10.35 | $12.49 | +1.31% |
| Week 3 | $8.28 | $10.42 | $13.11 | +1.97% |
| Week 4 | $8.04 | $10.49 | $13.68 | +2.64% |
| Week 5 | $7.85 | $10.56 | $14.20 | +3.31% |
| Week 6 | $7.68 | $10.63 | $14.71 | +3.98% |
| Week 7 | $7.53 | $10.70 | $15.19 | +4.66% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
P3 Health Partners Inc. is a patient-centered and physician-led population health management company that provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.
P3 Health Partners Inc. focuses on population health management within the healthcare sector, delivering care through its network of clinics and wellness centers. The name P3 Health Partners Inc. identifies the entity behind these services and its geographic footprint in the United States.
These details describe the basic profile: a healthcare provider organized around population health and clinical delivery, anchored by its founding in 2020 and its base in Henderson, Nevada.
The asset is P3 Health Partners Inc., trading under the symbol PIII, with a current price of $10.48.
It carries a market capitalization of $2.13B and is ranked 1887 in market listings.
Forecasts present a wide range of potential outcomes, with the average price projected to rise from $10.48 in 2026 to higher levels by 2030 and beyond. Notably, the 2030 max forecast is $31.44 and the 2050 max forecast is $188.49, indicating substantial upside possibilities over the longer term. The expected ROI spans from 0% in 2026 to as high as 682% in 2050, with a generally bullish tilt in later years.
A major floor 76.9% below — a decisive break under it would weaken the trend.
The nearest floor, 8.9% below — buyers have tended to step in here.
The nearest ceiling, 17.3% above — a clean break opens room to run.
A major ceiling 61.2% above — clearing it would confirm fresh momentum.
Key PIII support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PIII market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.27 | Sell | $10.28 | Sell |
| MA 10 | $10.20 | Buy | $10.27 | Sell |
| MA 20 | $10.31 | Sell | $10.39 | Sell |
| MA 50 | $11.37 | Sell | $9.87 | Buy |
| MA 100 | $7.29 | Buy | $8.38 | Buy |
| MA 200 | $6.01 | Buy | $7.65 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.36 | Neutral |
| Stoch RSI (14) | 59.57 | Neutral |
| CCI (20) | -15.71 | Neutral |
| Williams %R (14) | -49.44 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -2.01 | Sell |
| Bollinger %B (20,2) | 0.45 | Neutral |
| Stochastic %K (14) | 50.56 | Neutral |
| TRIX (15) | -0.27 | Sell |
| Awesome (5,34) | -0.53 | Sell |
| Ultimate (7,14,28) | 52.76 | Neutral |
| Momentum (10) | -0.89 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 10.56 | Sell |
| ADX (14) | 7.54 | Neutral |
| ATR (14) | 0.45 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 50.
Key moving averages show SMA50 at $11.12 and SMA200 at $5.99, framing near-term momentum and longer-term trend context.
Support is listed at $9.31 and resistance at $13.56, while the 30-day price range runs from $7.14 to $15.39, outlining the near-term trading band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.52 | $10.22 | $14.56 | 0% | Neutral | |
| $7.48 | $10.16 | $14.88 | -1% | Neutral | |
| $8.42 | $12.09 | $18.84 | +18% | Neutral | |
| $10.63 | $16.03 | $26.18 | +57% | Bullish | |
| $11.18 | $17.61 | $29.89 | +72% | Bullish | |
| $12.05 | $19.77 | $34.69 | +93% | Bullish | |
| $11.93 | $20.34 | $36.77 | +99% | Bullish | |
| $10.90 | $19.27 | $35.78 | +89% | Bullish | |
| $10.37 | $19.02 | $36.17 | +86% | Bullish | |
| $11.36 | $21.56 | $41.93 | +111% | Bullish | |
| $13.86 | $30.81 | $65.64 | +201% | Bullish | |
| $35.34 | $78.53 | $180.62 | +668% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.52 | $10.22 | $11.98 | +0.00% |
| August 2026 | $9.05 | $10.81 | $13.35 | +5.75% |
| September 2026 | $9.17 | $11.12 | $14.07 | +2.93% |
| October 2026 | $8.61 | $10.58 | $13.63 | -4.89% |
| November 2026 | $8.41 | $10.44 | $13.66 | -1.32% |
| December 2026 | $8.76 | $10.98 | $14.56 | +5.18% |
Click any year to see its month-by-month PIII forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The PIII price prediction for 2026 points to an average of $10.22 (low $1.52, high $14.56) — a potential gain of 0% on today's $10.22. Price action looks broadly range-bound.
In 2027, PIII is projected to trade between $7.48 and $14.88, averaging $10.16 — a potential decline of -1% from today's $10.22. That is -1% versus the projected 2026 average. A consolidation phase looks the most probable path here.
P3 Health Partners Inc.'s 2028 outlook centres on $12.09, within a $8.42 to $18.84 range. That is up +19% on the projected 2027 average. That marks a +18% change versus current levels. Price action looks broadly range-bound.
By 2029, PIII could reach as high as $26.18, with a base case around $16.03 and support toward $10.63 — roughly +57% from $10.22. Buyers look set to stay in control over this stretch.
Expect PIII to range from $11.18 to $29.89 through 2030. The $17.61 average target implies a +72% move from current prices. That is up +10% on the projected 2029 average. Momentum favours further upside here.
The PIII price prediction for 2031 points to an average of $19.77 (low $12.05, high $34.69) — a potential gain of +93% on today's $10.22. Buyers look set to stay in control over this stretch.
In 2032, PIII is projected to trade between $11.93 and $36.77, averaging $20.34 — a potential gain of +99% from today's $10.22. That is up +3% on the projected 2031 average. Momentum favours further upside here.
P3 Health Partners Inc.'s 2033 outlook centres on $19.27, within a $10.90 to $35.78 range. That is -5% versus the projected 2032 average. That marks a +89% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, PIII could reach as high as $36.17, with a base case around $19.02 and support toward $10.37 — roughly +86% from $10.22. Momentum favours further upside here.
Expect PIII to range from $11.36 to $41.93 through 2035. The $21.56 average target implies a +111% move from current prices. That is up +13% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The PIII price prediction for 2040 points to an average of $30.81 (low $13.86, high $65.64) — a potential gain of +201% on today's $10.22. Momentum favours further upside here.
In 2050, PIII is projected to trade between $35.34 and $180.62, averaging $78.53 — a potential gain of +668% from today's $10.22. That is up +155% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PIII today (≈ 97.847358 PIII) could be worth
$7,684.01
+$6,684.01 (+668%) by 2050 · US Dollar
Based on the average projected PIII price of $78.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PIIIwould be worth at today's price.
$1,000 invested in PIII on Jul 30, 2025 (≈ 136.986298 PIII) would be worth
$1,400
+$400 (+40.0%) today · 1.40× · US Dollar
Based on a PIII entry price of $7.3 vs. today's $10.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.31 | $1,097.74 | +9.8% |
| 1 month ago | $10.8 | $946.3 | -5.4% |
| 3 months ago | $2.93 | $3,488.05 | +248.8% |
| 6 months ago | $1.92 | $5,322.92 | +432.3% |
| 1 year ago | $7.3 | $1,400 | +40.0% |
| All time (5.0y) ago | $493 | $20.73 | -97.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PIII forecast.
Our base-case forecast reaches $20.00 around 2032.
Implied market cap at $20.00: $66.52M
The multi-year forecast shows several meaningful upside milestones. The average price is projected from $10.48 in 2026 to $18.15 in 2030 and $81.95 in 2050, while the long-run max rises to $31.44 in 2030 and $188.49 in 2050, with corresponding upside in ROIs (73.2% in 2030 and 682% in 2050).
From 2029 onward, the outlook strengthens, with the average reaching $16.71 in 2029 and associated bullish sentiment, climbing further through 2032 where the average is $21.08 and ROI is 101.2%. By 2040 the average is projected at $31.16 with a max of $68.36 and a 197.4% ROI, and by 2050 the average is $81.95 with a max of $188.49 and a 682% ROI.
Overall, the forecast shows a clear bullish trend in the late 2020s through 2050, but it also includes a cautious note: the 2027 year carries a negative ROI of -3.4%, illustrating that outcomes are not guaranteed and depend on future conditions.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $18.15, with a min of $11.24 and a max of $31.44, and a projected ROI of 73.2%.
The forecast includes bullish years from 2029 onward, with an average price of $16.71 in 2029 and ROIs of 59.4% in 2029, 73.2% in 2030, 96.9% in 2031, 101.2% in 2032, and up to 682% by 2050, though 2027 shows a negative ROI of -3.4%.
Yes, the max forecast by 2050 is $188.49, indicating a potential to exceed $100 within the forecast horizon, while earlier years show lower maximums (e.g., $68.36 by 2040).
Current price is $10.48. The near-term technical picture is NEUTRAL with RSI 50, SMA50 at $11.12, SMA200 at $5.99, support at $9.31, and resistance at $13.56, while the 30-day range runs from $7.14 to $15.39.
Market capitalization is $2.13B and the stock ranks 1887.
P3 Health Partners Inc. Community Discussion
0Share your P3 Health Partners Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.